Contrast Agents And Radiopharmaceuticals – Market Insights – Europe
The COVID-19 pandemic negatively impacted the European contrast agents and radiopharmaceutical market in 2020. Following the recovery, growth in the European market will be supported by the expanded use of imaging agents in CEUS and PET procedures. However, the market will be somewhat limited by ASP erosion in some segments and the continued concern over gadolinium and radiation exposure in certain modalities along with stringent reimbursement regulations in the European market.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for contrast agents and radiopharmaceuticals in Europe from 2019 through 2032.
Contrast agents and radiopharmaceutical market will grow modestly over the forecast period.
Which segments will see the greatest growth through 2032, and what factors will drive this growth?
What factors are hampering growth of some segments?
Looming concerns over the effects of gadolinium retention will negatively affect the use of contrast-enhanced MRI.
How has the EMA responded to studies that call into question the safety of GBCAs?
Which companies (and associated products) will benefit from the shift to macrocyclic GBCAs?
To what extent will these studies impact the MRI contrast agent market through 2032?
Product innovation and the expansion of approved indications will support market growth.
What new products are anticipated to enter the European contrast agent and radiopharmaceutical market?
How will approval for new indications and surgeon adoption of these will impact market growth?
Table of contents
- Contrast Agents And Radiopharmaceuticals - Market Insights - Europe
- Abstract
- Executive Summary
- COVID-19 Updates
- Market Highlights
- Contrast Agent and Radiopharmaceutical Market, by Product Type, Europe (USD), 2019u20132032
- Contrast Agent and Radiopharmaceutical Market Landscape, Europe (USD), 2022u00a0and 2032
- Competitive Highlights
- Contrast Agent and Radiopharmaceutical Procedure Market Share Rankings, by Product Type, Europe, 2022
- Competitive Insights
- Companies Mentioned
- Market Developments
- Recent Events in the Contrast Agent and Radiopharmaceutical Market, Europe
- Emerging Products for the Contrast Agent and Radiopharmaceutical Market, Europe
- Geographies Covered
- Geographies Covered, Europe
- Average Currency Exchange Rates
- Procedures and Products Covered
- Contrast Agent and Radiopharmaceutical Procedures and Products Covered, Europe
- COVID-19 Updates
- Key Report Updates
- Contrast Agent and Radiopharmaceutical Market
- Market Highlights
- Key Content Updates
- European Contrast Agent and Radiopharmaceutical Market Drivers
- European Contrast Agent and Radiopharmaceutical Market Limiters
- Contrast Agent and Radiopharmaceutical Market, by Product Type, Europe (USD), 2019u20132032
- Contrast Agent and Radiopharmaceutical Market, by Country, Europe (USD), 2019u20132032
- Market Definitions
- Market Forecast Data
- Contrast Agent and Radiopharmaceutical Procedures, by Product Type, Europe, 2019u20132032
- Contrast Agent and Radiopharmaceutical Procedures, by Country, Europe, 2019u20132032
- Contrast Agent and Radiopharmaceutical Market, by Product Type, Europe (USD and EUR), 2019u20132032
- Contrast Agent and Radiopharmaceutical Market, by Country, Europe (USD, EUR, and GBP), 2019u20132032
- Market Shares
- Contrast Agent and Radiopharmaceutical Procedure Market Shares, Europe, 2022
- Contrast Agent and Radiopharmaceutical Procedure Market Shares, by Country, Europe, 2022
- Contrast Agent and Radiopharmaceutical Procedure Market Shares, by Product Type, Europe, 2022
- Market Developments
- Recent Events in the Contrast Agent and Radiopharmaceutical Market, Europe
- Emerging Products for the Contrast Agent and Radiopharmaceutical Market, Europe
- Competitive Insights
- Bracco Competitive Insights
- Bayer HealthCare Competitive Insights
- GE Healthcare Competitive Insights
- Competitive Insights for Other Key Competitors
- Market Highlights
- Radiopharmaceutical Market
- Market Highlights
- Key Content Updates
- European Radiopharmaceutical Market Drivers
- European Radiopharmaceutical Market Limiters
- Radiopharmaceutical Market, by Product Type, Europe (USD), 2019u20132032
- Radiopharmaceutical Market, by Country, Europe (USD), 2019u20132032
- Market Definitions
- Market Forecast Data
- Radiopharmaceutical Market, by Product Type, Europe (USDu200b), 2019u20132032
- Radiopharmaceutical Market, by Product Type, Europe (EUR), 2019u20132032
- Radiopharmaceutical Market Growth, by Product Type, Europe, 2020u20132032
- Radiopharmaceutical Market, by Country, Europe (USD), 2019u20132032
- Radiopharmaceutical Market, by Country, Europe (EUR and GBP), 2019u20132032
- Radiopharmaceutical Market Growth, by Country, Europe, 2020u20132032
- Nuclear Medicine System Installed Base, by Product Type, Europe, 2019u20132032
- Nuclear Medicine System Installed Base, by Country, Europe, 2019u20132032
- SPECT Radiopharmaceutical Market, by Country, Europe (USD), 2019u20132032
- SPECT Radiopharmaceutical Market, by Country, Europe (EUR and GBP), 2019u20132032
- SPECT Radiopharmaceutical Market Growth, by Country, Europe, 2020u20132032
- SPECT System Installed Base, by Country, Europe, 2019u20132032
- PET Radiopharmaceutical Market, by Country, Europe (USD), 2019u20132032
- PET Radiopharmaceutical Market, by Country, Europe (EUR and GBP), 2019u20132032
- PET Radiopharmaceutical Market Growth, by Country, Europe, 2020u20132032
- PET System Installed Base, by Country, Europe, 2019u20132032
- Market Shares
- SPECT Radiopharmaceutical Procedure Market Shares, Europe, 2022
- SPECT Radiopharmaceutical Procedure Market Shares, by Country, Europe, 2022
- Competitive Insights
- Market Highlights
- CT and X-Ray Contrast Agent Market
- Market Highlights
- Key Content Updates
- European CT and X-Ray Contrast Agent Market Drivers
- European CT and X-Ray Contrast Agent Market Limiters
- CT and X-Ray Contrast Agent Market, by Product Type, Europe (USD), 2019u20132032
- CT and X-Ray Contrast Agent Market, by Country, Europe (USD), 2019u20132032
- Market Definitions
- Market Forecast Data
- CT and Xu2013Ray Contrast Agent Market, by Product Type, Europe (USD), 2019u20132032
- CT and Xu2013Ray Contrast Agent Market, by Product Type, Europe (EUR), 2019u20132032
- CT and X-Ray Contrast Agent Market Growth, by Product Type, Europe, 2020u20132032
- CT and Xu2013Ray Contrast Agent Market, by Country, Europe (USD), 2019u20132032
- CT and Xu2013Ray Contrast Agent Market, by Country, Europe (EUR and GBP), 2019u20132032
- CT and X-Ray Contrast Agent Market Growth, by Country, Europe, 2020u20132032
- CT and Xu2013Ray System Installed Base, by Country, Europe, 2019u20132032
- CT System Installed Base, by Country, Europe, 2019u20132032
- Xu2013Ray System Installed Base, by Country, Europe, 2019u20132032
- CT Contrast Agent Market, by Country, Europe (USD), 2019u20132032
- CT Contrast Agent Market, by Country, Europe (EUR and GBP), 2019u20132032
- CT Contrast Agent Market Growth, by Country, Europe, 2020u20132032
- Cardiovascular Xu2013Ray Contrast Agent Market, by Country, Europe (USDu200b), 2019u20132032
- Cardiovascular Xu2013Ray Contrast Agent Market, by Country, Europe (EURu200b and GBP), 2019u20132032
- Cardiovascular Xu2013Ray Contrast Agent Market Growth, by Country, Europe, 2020u20132032
- Conventional Xu2013Ray Contrast Agent Market, by Country, Europe (USDu200b), 2019u20132032
- Conventional Xu2013Ray Contrast Agent Market, by Country, Europe (EUR and GBP), 2019u20132032
- Conventional Xu2013Ray Contrast Agent Market Growth, by Country, Europe, 2020u20132032
- Market Shares
- CT and Xu2013Ray Contrast Agent Procedure Market Shares, Europe, 2022
- CT and Xu2013Ray Contrast Agent Procedure Market Shares, by Country, Europe, 2022
- Competitive Insights
- Market Highlights
- MRI Contrast Agent Market
- Market Highlights
- Key Content Updates
- European MRI Contrast Agent Market Drivers
- European MRI Contrast Agent Market Limiters
- MRI Contrast Agent Market, by Country, Europe (USD), 2019u20132032
- Market Definitions
- Market Forecast Data
- MRI Contrast Agent Market, by Country, Europe (USD), 2019u20132032
- MRI Contrast Agent Market, by Country, Europe (EUR and GBP), 2019u20132032
- MRI Contrast Agent Market Growth, by Country, Europe, 2020u20132032
- MRI System Installed Base, by Country, Europe, 2019u20132032
- Market Shares
- MRI Contrast Agent Procedure Market Shares, Europe, 2022
- MRI Contrast Agent Procedure Market Shares, by Country, Europe, 2022
- Competitive Insights
- Market Highlights
- Ultrasound Contrast Agent Market
- Market Highlights
- Key Content Updates
- European Ultrasound Contrast Agent Market Drivers
- European Ultrasound Contrast Agent Market Limiters
- Ultrasound Contrast Agent Market, by Country, Europe (USD), 2019u20132032
- Market Definitions
- Market Forecast Data
- Ultrasound Contrast Agent Market, by Country, Europe (USDu200b), 2019u20132032
- Ultrasound Contrast Agent Market, by Country, Europe (EUR and GBP), 2019u20132032
- Ultrasound Contrast Agent Market Growth, by Country, Europe, 2020u20132032
- Market Share Rankings
- Ultrasound Contrast Agent Procedure Market Share Rankings, Europe, 2022
- Competitive Insights
- Market Highlights
- Appendix
- Abbreviations
- Bibliography
- Abbreviations
Suchitra Ghoshal is an associate healthcare research & data analyst within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Clarivate, specializing in the biosurgical agent market. Suchitra holds a Bachelor’s degree in Life Sciences from Delhi University, and a Master’s degree in Environmental Science from Guru Gobind Singh Indraprastha University, New Delhi.